Clinical Trials Browser

Phase 1 × Myasthenia Gravis × thymoglobulin × Clear all

NCT00424489 2018-08-31

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Phase 1 Terminated

9 enrolled 8 charts

Myasthenia Gravis